Cetuximab (Erbitux) Manufacturer: ImClone Systems, Inc., Branchburg, NJ, and Bristol-Myers Squibb, Princeton, NJ Indication: Cetuximab is indicated for use in combination with radiation therapy to treat patients with squamous cell cancer of the head and neck that cannot be removed by surgery. Cetuximab is also approved as monotherapy for patients whose head and neck cancer [...]

A large-scale clinical trial comparing the ARB valsartan (Diovan drug) with the same ARB plus HCTZ revealed unexpected findings and raised new questions. The ARB/HCTZ combination lowered BP successfully but significantly increased the inflammatory marker hsCRP Professor Paul Ridker, MD, MPH, study author of the Val-MARC trial (POzlsartan: Managing BP Aggressively and Evaluating deductions in [...]